120 related articles for article (PubMed ID: 11226331)
21. The paradigm of restenosis following percutaneous transluminal coronary angioplasty.
Preisack MB; Karsch KR
Eur Heart J; 1993 Nov; 14 Suppl I():187-92. PubMed ID: 8293774
[TBL] [Abstract][Full Text] [Related]
22. Effect of local heating on restenosis and in-stent neointimal hyperplasia in the atherosclerotic rabbit model: a dose-ranging study.
Brasselet C; Durand E; Addad F; Vitry F; Chatellier G; Demerens C; Lemitre M; Garnotel R; Urbain D; Bruneval P; Lafont A
Eur Heart J; 2008 Feb; 29(3):402-12. PubMed ID: 18212388
[TBL] [Abstract][Full Text] [Related]
23. Aspirin, but not NO-releasing aspirin (NCX-4016), interacts with selective COX-2 inhibitors to aggravate gastric damage and inflammation.
Wallace JL; Zamuner SR; McKnight W; Dicay M; Mencarelli A; del Soldato P; Fiorucci S
Am J Physiol Gastrointest Liver Physiol; 2004 Jan; 286(1):G76-81. PubMed ID: 14665439
[TBL] [Abstract][Full Text] [Related]
24. Nitric oxide (NO)-releasing naproxen (HCT-3012 [(S)-6-methoxy-alpha-methyl-2-naphthaleneacetic Acid 4-(nitrooxy)butyl ester]) interactions with aspirin in gastric mucosa of arthritic rats reveal a role for aspirin-triggered lipoxin, prostaglandins, and NO in gastric protection.
Fiorucci S; Di Lorenzo A; Renga B; Farneti S; Morelli A; Cirino G
J Pharmacol Exp Ther; 2004 Dec; 311(3):1264-71. PubMed ID: 15297470
[TBL] [Abstract][Full Text] [Related]
25. Restenosis following placement of an intracoronary heparin treated tantulum stent in the hyperlipidemic miniature swine model.
Jenkins JS; Webel R; Laughlin MH; Rowland SM; Yoklavich MF; Amann JF; Branson K; Myers PR
J Invasive Cardiol; 1995; 7(6):173-82. PubMed ID: 10155102
[TBL] [Abstract][Full Text] [Related]
26. Restenosis after percutaneous transluminal coronary angioplasty in patients with non-insulin-dependent diabetes mellitus (NIDDM).
Asakura Y; Suzuki M; Nonogi H; Haze K; Sato A; Inada H; Okuda Y; Yamashita K; Harano Y
J Cardiovasc Risk; 1998; 5(5-6):331-4. PubMed ID: 9920005
[TBL] [Abstract][Full Text] [Related]
27. Nitric oxide-releasing aspirin decreases vascular injury by reducing inflammation and promoting apoptosis.
Yu J; Rudic RD; Sessa WC
Lab Invest; 2002 Jul; 82(7):825-32. PubMed ID: 12118084
[TBL] [Abstract][Full Text] [Related]
28. NCX 4040, an NO-donating acetylsalicylic acid derivative: efficacy and mechanisms of action in cancer cells.
Tesei A; Zoli W; Fabbri F; Leonetti C; Rosetti M; Bolla M; Amadori D; Silvestrini R
Nitric Oxide; 2008 Sep; 19(2):225-36. PubMed ID: 18472019
[TBL] [Abstract][Full Text] [Related]
29. In vivo antithrombotic effects of a nitric oxide-releasing aspirin derivative, NCX-4016.
Wallace JL; Muscara MN; McKnight W; Dicay M; Del Soldato P; Cirino G
Thromb Res; 1999 Jan; 93(1):43-50. PubMed ID: 10065898
[No Abstract] [Full Text] [Related]
30. Antiangiogenesis: a suitable preventive treatment of restenosis.
Beranek JT
Cathet Cardiovasc Diagn; 1993 Feb; 28(2):184-6. PubMed ID: 7680604
[No Abstract] [Full Text] [Related]
31. Some unanswered questions in re-stenosis prevention research.
Daida H
J Atheroscler Thromb; 2005; 12(6):307. PubMed ID: 16394613
[No Abstract] [Full Text] [Related]
32. [Experimental study progress in the pharmacotherapy of vascular restenosis].
Zhang J; Zhang Y; Liu Z
Zhonghua Xin Xue Guan Bing Za Zhi; 2015 Oct; 43(10):915-8. PubMed ID: 26653001
[No Abstract] [Full Text] [Related]
33. Low dose aspirin prevents endothelial dysfunction in the aorta and foetal loss in pregnant mice infected with influenza A virus.
Coward-Smith M; Liong S; Oseghale O; Erlich JR; Miles MA; Liong F; Brassington K; Bozinovski S; Vlahos R; Brooks RD; Brooks DA; O'Leary JJ; Selemidis S
Front Immunol; 2024; 15():1378610. PubMed ID: 38638436
[TBL] [Abstract][Full Text] [Related]
34. Gaseous Mediators as a Key Molecular Targets for the Development of Gastrointestinal-Safe Anti-Inflammatory Pharmacology.
Danielak A; Wallace JL; Brzozowski T; Magierowski M
Front Pharmacol; 2021; 12():657457. PubMed ID: 33995080
[TBL] [Abstract][Full Text] [Related]
35. Targeted Nitric Oxide Delivery by Supramolecular Nanofibers for the Prevention of Restenosis After Arterial Injury.
Bahnson ES; Kassam HA; Moyer TJ; Jiang W; Morgan CE; Vercammen JM; Jiang Q; Flynn ME; Stupp SI; Kibbe MR
Antioxid Redox Signal; 2016 Mar; 24(8):401-18. PubMed ID: 26593400
[TBL] [Abstract][Full Text] [Related]
36. Nitric oxide delivery via a permeable balloon catheter inhibits neointimal growth after arterial injury.
Havelka GE; Moreira ES; Rodriguez MP; Tsihlis ND; Wang Z; MartÃnez J; Hrabie JA; Kiefer LK; Kibbe MR
J Surg Res; 2013 Mar; 180(1):35-42. PubMed ID: 23164361
[TBL] [Abstract][Full Text] [Related]
37. NO-donating aspirin and aspirin partially inhibit age-related atherosclerosis but not radiation-induced atherosclerosis in ApoE null mice.
Hoving S; Heeneman S; Gijbels MJ; te Poele JA; Bolla M; Pol JF; Simons MY; Russell NS; Daemen MJ; Stewart FA
PLoS One; 2010 Sep; 5(9):e12874. PubMed ID: 20877628
[TBL] [Abstract][Full Text] [Related]
38. Notch signaling regulates endothelial progenitor cell activity during recovery from arterial injury in hypercholesterolemic mice.
Ii M; Takeshita K; Ibusuki K; Luedemann C; Wecker A; Eaton E; Thorne T; Asahara T; Liao JK; Losordo DW
Circulation; 2010 Mar; 121(9):1104-12. PubMed ID: 20176991
[TBL] [Abstract][Full Text] [Related]
39. Cyclic GMP signaling in cardiovascular pathophysiology and therapeutics.
Tsai EJ; Kass DA
Pharmacol Ther; 2009 Jun; 122(3):216-38. PubMed ID: 19306895
[TBL] [Abstract][Full Text] [Related]
40. Neointimal formation is reduced after arterial injury in human crp transgenic mice.
Danenberg HD; Grad E; Swaminathan RV; Chen Z; Seifert P; Szalai AJ; Lotan C; Simon DI; Edelman ER
Atherosclerosis; 2008 Nov; 201(1):85-91. PubMed ID: 18358478
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
